NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 29,690,135
- Share change
- +20,297,042
- Total reported value
- $112,309,052
- Put/Call ratio
- 169%
- Price per share
- $3.78
- Number of holders
- 42
- Value change
- +$77,501,715
- Number of buys
- 31
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Everest Medicines Ltd |
13D/G
|
Everest Medicines Limited |
16%
|
42,524,716
|
$90,577,645 | $0 | 05 Aug 2025 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.3%
|
5,980,568
|
$14,472,975 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.43%
|
1,132,563
|
$2,740,919 | — | 30 Jun 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.33%
|
876,353
|
$2,121,000 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.08%
|
209,383
|
$506,707 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
184,845
|
$447,325 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.05%
|
136,471
|
$330,260 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
122,405
|
$296,220 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
113,262
|
$274,094 | — | 30 Jun 2025 | |
| Ariose Capital Management Ltd |
13F
|
Company |
0.04%
|
96,455
|
$233,421 | — | 30 Jun 2025 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$180,830 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,700
|
$154,154 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
58,358
|
$141,227 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
58,295
|
$141,074 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
54,562
|
$132,040 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
37,537
|
$90,840 | — | 30 Jun 2025 | |
| CreativeOne Wealth, LLC |
13F
|
Company |
0.01%
|
37,430
|
$90,581 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
30,370
|
$73,495 | — | 30 Jun 2025 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
28,760
|
$69,599 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.01%
|
27,800
|
$67,276 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
25,110
|
$60,000 | — | 30 Jun 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0%
|
12,821
|
$31,027 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
10,682
|
$25,850 | — | 30 Jun 2025 | |
| BAXTER BROS INC |
13F
|
Company |
0%
|
10,000
|
$24,200 | — | 30 Jun 2025 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0%
|
10,000
|
$24,200 | — | 30 Jun 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0%
|
1,248
|
$3,020 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
1,000
|
$2,420 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
566
|
$1,369 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
333
|
$805 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
305
|
$738 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$121 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
30
|
$72 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Jun 2025 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2025
As of 30 Sep 2025,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,690,135 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, HHLR ADVISORS, LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, Ariose Capital Management Ltd, Exome Asset Management LLC, Siren, L.L.C., Candriam S.C.A., Woodline Partners LP, and Point72 Hong Kong Ltd.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
32
Q3 2025 holders
42
Holder diff
10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.